2024 World Conference on Lung Cancer (WCLC) - ePosters-EP.17A.03 NOVA: A Conversational Generative Agent for Thoracic Oncology Decision-Making

Pdf Summary

The document outlines the creation and impact of NOVA, a conversational AI agent designed to aid decision-making in the management of lung cancer and mesothelioma. Developed by Luis Pino and collaborators from institutions such as OxLER SAS and Universidad de los Andes, NOVA addresses the gap in specialized thoracic oncology knowledge, especially prevalent in low- and middle-income countries where there is a scarcity of specialized oncologists.<br /><br />NOVA is designed to augment the capabilities of general oncologists who often deal with complex diseases in isolated and underserved areas. The AI tool provides timely and precise clinical guidance by leveraging the latest medical knowledge. Specifically, it facilitates rapid data analysis, supports informed treatment decisions, personalizes treatment plans, and continuously updates itself with new medical insights. <br /><br />The tool has been successfully piloted in a private clinic in Colombia, demonstrating substantial improvements in efficiency and accuracy during clinical workflows. By integrating sophisticated AI with expert-reviewed content, NOVA positions itself as a vital tool in the clinical setup, enhancing decision-making and potentially improving patient outcomes.<br /><br />Future plans for NOVA include a prospective validation trial to further certify its practicality and effectiveness in real-world settings. The creators aim to expand NOVA's capabilities across the spectrum of thoracic oncology diseases, thereby extending its utility beyond current applications. This progressive development suggests NOVA could become an essential resource for oncologists across the region, contributing significantly to the fight against thoracic cancers. <br /><br />Acknowledgments were made to Ghenova Digital for adapting their digital technology to NOVA, as well as to various field experts for their crucial contributions in shaping the project.

Asset Subtitle

Luis PINO

Meta Tag

Speaker Luis PINO

Topic Global Health, Health Services, and Health Economics

Keywords

NOVA

conversational AI

lung cancer

mesothelioma

thoracic oncology

decision-making

Luis Pino

low-income countries

clinical guidance

personalized treatment